Heron Therapeutics (HRTX)

$2.15 0.00 (N/A)
Market Cap 321.91M
Revenue (ttm) 144.29M
Net Income (ttm) -13.58M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9.41%
Debt to Equity Ratio -0.89
Volume 1,743,616
Avg Vol 1,510,436
Day's Range N/A - N/A
Shares Out 152.56M
Stochastic %K 85%
Beta 1.16
Analysts Strong Sell
Price Target $6.25

Company Profile

Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed na...

Industry: Biotechnology
Sector: Healthcare
Phone: (858) 251-4400
Address:
100 Regency Forest Drive, Suite 300, Cary, United States
bambus3001
bambus3001 Jun. 25 at 8:12 PM
$HRTX Irgendwie sagt das Bauchgefühl ,das Heron in KÜRZE ein Übernahmeangebot präsentiert .Es ist zu still um den Wert,jeder denkt negativ weil die Umsätze noch nicht genug Schwung haben ,doch diese Perle ist meines Erachtens seit neue am Ruder stehn ,super in Fahrt gekommen.Very Bullish weiterhin!!!!
0 · Reply
republicansrcrooks
republicansrcrooks Jun. 25 at 4:07 PM
$HRTX Good volume, let's get going!!
0 · Reply
jacksonjohn750
jacksonjohn750 Jun. 25 at 4:04 PM
$HRTX strange happenings!!!
0 · Reply
Braddog
Braddog Jun. 25 at 12:00 AM
$HRTX So everyday I’m invested in Heron is just more depressing. Sales are growing at a SNAILS PACE! Like what the analyst said on the last earrings call “WHEN ARE SALES GOING TO TAKE OFF?” They are growing compared to the previous years qtr, but on an overall bases, they suck!!!! CC should have sold Heron when he first took over. This is brutal! I curse the day I heard about this company $150M/year of sales in Zyn is years away! 😡😡😡😡😡😡😡😡😡
1 · Reply
bambus3001
bambus3001 Jun. 24 at 7:55 PM
$HRTX Und weiter zukaufen ist angesagt .Alle spielen kryptische Sachen ,dabei ist Bio was Handfestes.
1 · Reply
Judykay
Judykay Jun. 24 at 5:51 PM
$HRTX Whoa!
0 · Reply
Smartynow
Smartynow Jun. 24 at 4:55 PM
$HRTX shorts are playing with 🔥
1 · Reply
jacksonjohn750
jacksonjohn750 Jun. 24 at 1:42 PM
$HRTX almost want to dump it and buy stxs instead!
1 · Reply
notaedj
notaedj Jun. 23 at 9:34 PM
$HRTX man that YTD is such a good looking chart
0 · Reply
HorizonBull
HorizonBull Jun. 23 at 9:08 PM
$HRTX nice move today
0 · Reply
Latest News on HRTX
Heron Therapeutics: Q1 Paints A Potentially Rosy Picture For 2025

May 7, 2025, 3:38 PM EDT - 7 weeks ago

Heron Therapeutics: Q1 Paints A Potentially Rosy Picture For 2025

Heron Therapeutics, Inc. (HRTX) Q1 2025 Earnings Call Transcript

May 6, 2025, 11:38 AM EDT - 7 weeks ago

Heron Therapeutics, Inc. (HRTX) Q1 2025 Earnings Call Transcript

Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates

May 6, 2025, 7:45 AM EDT - 7 weeks ago

Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates

Heron Therapeutics Announces Settlement with Mylan Related to CINVANTI® and APONVIE® Patent Litigations

May 6, 2025, 7:30 AM EDT - 7 weeks ago

Heron Therapeutics Announces Settlement with Mylan Related to CINVANTI® and APONVIE® Patent Litigations

Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer

Apr 28, 2025, 6:55 PM EDT - 2 months ago

Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer

Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025

Apr 22, 2025, 4:05 PM EDT - 2 months ago

Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025

Heron Therapeutics, Inc. (HRTX) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 12:07 PM EST - 4 months ago

Heron Therapeutics, Inc. (HRTX) Q4 2024 Earnings Call Transcript

Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Updates

Feb 27, 2025, 7:45 AM EST - 4 months ago

Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Updates

Heron Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results On Thursday, February 27, 2025

Feb 13, 2025, 4:20 PM EST - 4 months ago

Heron Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results On Thursday, February 27, 2025

Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina

Dec 23, 2024, 4:05 PM EST - 6 months ago

Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina

Relief For Heron Therapeutics After The Court Win On Cinvanti

Dec 4, 2024, 3:01 PM EST - 7 months ago

Relief For Heron Therapeutics After The Court Win On Cinvanti

U.S. District Court Upholds Validity of CINVANTI® Patents

Dec 3, 2024, 4:36 PM EST - 7 months ago

U.S. District Court Upholds Validity of CINVANTI® Patents

Heron Therapeutics, Inc. (HRTX) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 11:45 AM EST - 8 months ago

Heron Therapeutics, Inc. (HRTX) Q3 2024 Earnings Call Transcript

Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance

Nov 12, 2024, 7:55 AM EST - 8 months ago

Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance

Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors

Nov 4, 2024, 5:00 PM EST - 8 months ago

Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors

Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024

Oct 29, 2024, 4:05 PM EDT - 8 months ago

Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024

Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous Fluids

Oct 10, 2024, 4:08 PM EDT - 9 months ago

Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous Fluids

Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")

Sep 25, 2024, 8:00 AM EDT - 9 months ago

Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")

Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer

Sep 3, 2024, 8:00 AM EDT - 10 months ago

Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer

Heron Therapeutics, Inc., (HRTX) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 10:14 AM EDT - 11 months ago

Heron Therapeutics, Inc., (HRTX) Q2 2024 Earnings Call Transcript

Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance

Aug 6, 2024, 4:05 PM EDT - 11 months ago

Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance

Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024

Jul 30, 2024, 4:05 PM EDT - 11 months ago

Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024

Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System

Jul 15, 2024, 8:00 AM EDT - 1 year ago

Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System

Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")

Jul 2, 2024, 8:00 AM EDT - 1 year ago

Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")

Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")

May 29, 2024, 8:05 AM EDT - 1 year ago

Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")

Heron Therapeutics, Inc. (HRTX) Q1 2024 Earnings Call Transcript

May 7, 2024, 2:38 PM EDT - 1 year ago

Heron Therapeutics, Inc. (HRTX) Q1 2024 Earnings Call Transcript

Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates

May 7, 2024, 8:00 AM EDT - 1 year ago

Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates

Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

Apr 24, 2024, 8:00 AM EDT - 1 year ago

Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

Heron Therapeutics: Zynrelef Potentially Eases Shareholder Pain

Apr 16, 2024, 4:24 PM EDT - 1 year ago

Heron Therapeutics: Zynrelef Potentially Eases Shareholder Pain

Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City

Apr 11, 2024, 4:05 PM EDT - 1 year ago

Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City

Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference

Mar 28, 2024, 4:05 PM EDT - 1 year ago

Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference

Heron Therapeutics, Inc. (HRTX) Q4 2023 Earnings Call Transcript

Mar 12, 2024, 10:35 PM EDT - 1 year ago

Heron Therapeutics, Inc. (HRTX) Q4 2023 Earnings Call Transcript

Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates

Mar 12, 2024, 4:05 PM EDT - 1 year ago

Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates

Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024

Feb 28, 2024, 8:00 AM EST - 1 year ago

Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024

Heron Therapeutics Is Out Of Survival Mode

Feb 17, 2024, 1:54 AM EST - 1 year ago

Heron Therapeutics Is Out Of Survival Mode

Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures

Jan 23, 2024, 8:00 PM EST - 1 year ago

Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures

Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain

Jan 7, 2024, 5:00 PM EST - 1 year ago

Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain

Heron Therapeutics Gets Back On Track

Dec 29, 2023, 3:14 PM EST - 1 year ago

Heron Therapeutics Gets Back On Track

Why Heron Therapeutics Is A Compelling Buy Into 2024

Nov 30, 2023, 9:00 AM EST - 1 year ago

Why Heron Therapeutics Is A Compelling Buy Into 2024

Heron Therapeutics, Inc. (HRTX) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 7:45 PM EST - 1 year ago

Heron Therapeutics, Inc. (HRTX) Q3 2023 Earnings Call Transcript

Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance

Nov 14, 2023, 4:05 PM EST - 1 year ago

Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance

Heron Therapeutics to Report Third Quarter 2023 Financial Results On Tuesday, November 14, 2023

Nov 7, 2023, 4:05 PM EST - 1 year ago

Heron Therapeutics to Report Third Quarter 2023 Financial Results On Tuesday, November 14, 2023

Heron Therapeutics, Inc. (HRTX) Q2 2023 Earnings Call Transcript

Aug 14, 2023, 6:48 PM EDT - 2 years ago

Heron Therapeutics, Inc. (HRTX) Q2 2023 Earnings Call Transcript

Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates

Aug 14, 2023, 4:05 PM EDT - 2 years ago

Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates

Heron Therapeutics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023

Aug 7, 2023, 4:05 PM EDT - 2 years ago

Heron Therapeutics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023

Heron Therapeutics: Restructuring Brings About A New Dawn

Jul 28, 2023, 3:57 PM EDT - 2 years ago

Heron Therapeutics: Restructuring Brings About A New Dawn

Heron Therapeutics Announces Cost Reduction Plan and Restructuring

Jul 24, 2023, 9:02 AM EDT - 2 years ago

Heron Therapeutics Announces Cost Reduction Plan and Restructuring

Heron Therapeutics Announces $30 Million Private Placement Financing

Jul 24, 2023, 9:00 AM EDT - 2 years ago

Heron Therapeutics Announces $30 Million Private Placement Financing

HTGC

Heron Therapeutics Announces Appointment of Ira Duarte as Chief Financial Officer

Jun 23, 2023, 4:05 PM EDT - 2 years ago

Heron Therapeutics Announces Appointment of Ira Duarte as Chief Financial Officer

Heron Therapeutics Announces Appointment of William Forbes, Pharm.D. as Chief Development Officer

Jun 12, 2023, 9:00 AM EDT - 2 years ago

Heron Therapeutics Announces Appointment of William Forbes, Pharm.D. as Chief Development Officer

bambus3001
bambus3001 Jun. 25 at 8:12 PM
$HRTX Irgendwie sagt das Bauchgefühl ,das Heron in KÜRZE ein Übernahmeangebot präsentiert .Es ist zu still um den Wert,jeder denkt negativ weil die Umsätze noch nicht genug Schwung haben ,doch diese Perle ist meines Erachtens seit neue am Ruder stehn ,super in Fahrt gekommen.Very Bullish weiterhin!!!!
0 · Reply
republicansrcrooks
republicansrcrooks Jun. 25 at 4:07 PM
$HRTX Good volume, let's get going!!
0 · Reply
jacksonjohn750
jacksonjohn750 Jun. 25 at 4:04 PM
$HRTX strange happenings!!!
0 · Reply
Braddog
Braddog Jun. 25 at 12:00 AM
$HRTX So everyday I’m invested in Heron is just more depressing. Sales are growing at a SNAILS PACE! Like what the analyst said on the last earrings call “WHEN ARE SALES GOING TO TAKE OFF?” They are growing compared to the previous years qtr, but on an overall bases, they suck!!!! CC should have sold Heron when he first took over. This is brutal! I curse the day I heard about this company $150M/year of sales in Zyn is years away! 😡😡😡😡😡😡😡😡😡
1 · Reply
bambus3001
bambus3001 Jun. 24 at 7:55 PM
$HRTX Und weiter zukaufen ist angesagt .Alle spielen kryptische Sachen ,dabei ist Bio was Handfestes.
1 · Reply
Judykay
Judykay Jun. 24 at 5:51 PM
$HRTX Whoa!
0 · Reply
Smartynow
Smartynow Jun. 24 at 4:55 PM
$HRTX shorts are playing with 🔥
1 · Reply
jacksonjohn750
jacksonjohn750 Jun. 24 at 1:42 PM
$HRTX almost want to dump it and buy stxs instead!
1 · Reply
notaedj
notaedj Jun. 23 at 9:34 PM
$HRTX man that YTD is such a good looking chart
0 · Reply
HorizonBull
HorizonBull Jun. 23 at 9:08 PM
$HRTX nice move today
0 · Reply
HorizonBull
HorizonBull Jun. 23 at 6:32 PM
$HRTX
0 · Reply
jacksonjohn750
jacksonjohn750 Jun. 23 at 6:27 PM
$HRTX another upgrade leak?
1 · Reply
jacksonjohn750
jacksonjohn750 Jun. 23 at 6:21 PM
$HRTX Why go up.. when you know you only do that to go down after..
0 · Reply
bambus3001
bambus3001 Jun. 23 at 5:14 PM
$HRTX 4 G. Regel
0 · Reply
AlwaysMoneySZN
AlwaysMoneySZN Jun. 23 at 3:27 PM
$HRTX
0 · Reply
Dlbok
Dlbok Jun. 23 at 3:02 PM
$HRTX 2.750
1 · Reply
bambus3001
bambus3001 Jun. 23 at 2:19 PM
$HRTX keiner hat momentan Lust auf diese Perle,ein verborgener Schatz ,der noch gehoben wird.!! Sehr Bullish
1 · Reply
Judykay
Judykay Jun. 21 at 2:30 AM
$KODK $IBRX $HRTX How I love everyone here yet HATE how I am stuck in fantastic stocks.
1 · Reply
Judykay
Judykay Jun. 21 at 2:25 AM
$HRTX
0 · Reply
Caesar65
Caesar65 Jun. 20 at 6:56 PM
$HRTX I am going to go out on a limb and say we close at 1.99.
2 · Reply
Ckwoods
Ckwoods Jun. 20 at 5:30 PM
$HRTX this really needs to close above 2
0 · Reply
Caesar65
Caesar65 Jun. 20 at 1:58 PM
$HRTX What a shock sitting right at 2. This was obvious 3 weeks ago when they took this down they were not going to pay June 2 calls. Optimistic next week we head back up as there is nothing positive to see today.
0 · Reply